Avinger, Inc. (AVGR) Financials

AVGR Assets vs Liabilities

DateAssetsLiabilities
2023-09-30 17.8 million 19.2 million
2023-06-30 16.9 million 23.5 million
2023-03-31 20.5 million 22.0 million
2022-12-31 24.2 million 20.0 million

AVGR Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-09-30 -3.5 million 219000
2023-06-30 -3.3 million 239000
2023-03-31 -4.2 million 245000
2022-12-31 -2.7 million -90999

AVGR Net Income

No data available :(

AVGR Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-09-30 8.7 million - 1.4 million
2023-06-30 7.1 million - 1.7 million
2023-03-31 10.4 million - 1.9 million
2022-12-31 14.6 million - 2.2 million

AVGR Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-09-30 698000
2023-06-30 609400
2023-03-31 547933
2022-12-31 504600

AVGR Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-09-30 8000 1.0 million 3.4 million -
2023-06-30 - 988000 3.3 million -
2023-03-31 - 1.4 million 3.5 million -
2022-12-31 20000 1.1 million 3.4 million -

AVGR Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-09-30 1.8 million 1.4 million
2023-06-30 2.0 million 1.4 million
2023-03-31 1.9 million 1.3 million
2022-12-31 2.0 million 1.3 million

AVGR

Price: $3.68

52 week price:
2.50
18.00

Earnings Per Share: -23.31 USD

P/E Ratio: -0.09

Exchange: NCM

Sector: Healthcare

Industry: Medical Instruments & Supplies

Volume: 84000

Ebitda: -8.5 million

Market Capitalization: 5.7 million

Links: